TCF12 and neoplasm: In our present study, the TCF12–MALAT1 alliance is significantly associated with a β-catenin-independent induction of cyclin D1 gene expression, which acts as a risk factor for CRC patient mortality, associated more with tumor recurrence than with metastasis.